Global Anti-Infectives Industry Examined in New Topical Study Most Recently Published at MarketPublishers.com
07 Feb 2012 • by Natalie Aster
LONDON – The area of anti-infectives represents an exciting frontier for development of potential life-saving products. However, there are a number of issues and trends that have a direct influence on this market and the manufacturer’s ability to successfully operate in the market.
The market is primarily impacted by such issues as drug resistance, HIV trends, cost, and access to drug therapy, other immunocompromised population issues, alliances and partnerships, new developments, Rx-to-OTC switches.
New market research report "World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)" worked out by Kalorama Information has been recently published by Market Publishers Ltd.
World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Published: February, 2012
Price: US$ 3.800,00
The report highlights three key segments of treatment:
- Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals)
- Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines, Others)
- Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors, Protease Inhibitors, Other Antivirals)
The report examines both currently marketed and late stage development products. Revenues for each segment were generated using dollar and unit sales for each product. It covers statistical information for infections by type worldwide, with special emphasis on the U.S. and Europe. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers.
More new market research reports by the publisher can be found at Kalorama Information page.